Adynovate

Adynovate Indications/Uses

Manufacturer:

Takeda

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in children and adults with hemophilia A (congenital factor VIII deficiency) for: On-demand treatment and control of bleeding episodes; Perioperative management; Routine prophylaxis to reduce the frequency of bleeding episodes.
Limitation of Use: ADYNOVATE is not indicated for the treatment of von Willebrand disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in